Skip to main content

and
  1. No Access

    Article

    Hommage au Pr Maurice Tubiana

    F. Eschwège in Oncologie (2013)

  2. Article

    Open Access

    Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation

    Low-dose hyper-radiosensitivity (HRS) (below 0.5 Gy) has been extensively documented in the past few years. The molecular basis of this phenomenon remains largely unknown and the purpose of this study was to i...

    S Vaganay-Juéry, C Muller, E Marangoni, B Abdulkarim in British Journal of Cancer (2000)

  3. Article

    Open Access

    Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment

    The variation in the risk of solid second malignant neoplasms (SMN) with time since first cancer during childhood has been previously reported. However, no study has been performed that controls for the distri...

    F de Vathaire, M Hawkins, S Campbell, O Oberlin, M-A Raquin in British Journal of Cancer (1999)

  4. No Access

    Chapter and Conference Paper

    Treatment of Oropharynx Carcinomas: Experience at the Institut Gustave-Roussy

    Radiotheraphy (RT) alone is he preffered treatment of oropharynx carcinomas T1, T2, N0 and N1 at te Institut Gustave-Roussy (IGR). More advanced or ulcerative tumours are treated with surgery combined with RT....

    F. Eschwège, P. Wibault, A. Lusinchi in Carcinoma of the Oral Cavity and Oropharynx (1994)

  5. No Access

    Article

    Principles and techniques of irradiation for the N0 neck

    The absence of palpable lymph nodes is one of the important elements in the choice of treatment of head and neck cancers. Irradiation of the neck represents one possible treatment chosen on the basis of histor...

    F. Eschwege, A. Bridier, B. Luboinski in European Archives of Oto-Rhino-Laryngology (1993)

  6. No Access

    Chapter and Conference Paper

    Perioperative chemotherapy in hypopharyngeal squamous cell carcinomas (SCC)

    This study was designed to reduce the rate of distant metastasis and lessen the rate of locoregional recurrences of hypopharyngeal SCC by adding to the initial chemotherapy a post-operative chemotherapy, befor...

    G. Mamelle, C. Domenge, F. Eschwege in Proceedings of the 3rd International Congr… (1991)

  7. No Access

    Chapter

    Post-Radiotherapy Adjuvant Chemotherapy of Regionally Advanced UNPC: Increase in Disease Free Survival

    38 patients with NPC, most of them from North Africa and South of Italy, with histo and serological diagnosis of UNPC (undifferentiated nasopharyngeal carcinoma), seen from January ‘83 till December ’84 at the In...

    C. Domenge, J. L. Marin, J. P. Droz, F. Eschwege in Epstein-Barr Virus and Human Disease (1987)

  8. No Access

    Chapter

    IgA/EA: Prognosis Marker for Relapse among NPC Patients with Complete Remission after Radiotherapy

    A longitudinal multicenter study on nasopharyngeal carcinoma (NPC) was initiated in 1979, with the aim of evaluating the EBV antibody response at various postradiotherapy follow-ups for predicting the long-ter...

    G. de-The, F. de Vathaire, H. Sancho-Garnier in Epstein-Barr Virus and Human Disease (1987)

  9. No Access

    Chapter

    Electron Therapy as a Postoperative Modality for Head and Neck Cancers

    Electron therapy, as a postoperative medium for head and neck cancers, has been used for many years at the Gustave-Roussy Institute in Villejuif. This therapy became possible after an Almis-Chalmers betatron w...

    F. Eschwege, P. Wibault, J. M. Richard in High Energy Electrons in Radiation Therapy (1980)

  10. No Access

    Chapter

    First Results of a Randomized Trial on Immunotherapy of Head and Neck Tumors

    Trials of active nonspecific immunotherapy as adjuvant therapy for tumors have increased dramatically in number since the results that have been published on acute leukemia [6] and melanoma [3, 5, 7–9]. In spi...

    J. L. Amiel, H. Sancho-Garnier in Adjuvant Therapies and Markers of Post-Sur… (1979)